Sort   by:  
 Page size 
UnknownPhase I study of decitabine in combination with vorinostat in patients with advanced solid tumors and non-Hodgkin's lymphomas.
Not available
S-EPMC2997755 | biostudies-literature
UnknownSpatially distinct tumor immune microenvironments stratify triple-negative breast cancers.
Not available
S-EPMC6436884 | biostudies-literature
UnknownTargeting CXCL12/CXCR4 and myeloid cells to improve the therapeutic ratio in patient-derived cervical cancer models treated with radio-chemotherapy.
Not available
S-EPMC6738100 | biostudies-literature
UnknownIntegrated (epi)-Genomic Analyses Identify Subgroup-Specific Therapeutic Targets in CNS Rhabdoid Tumors.
Not available
S-EPMC5500911 | biostudies-literature
UnknownBinimetinib and encorafenib for the treatment of advanced solid tumors with non-V600E BRAF mutations: results from the Phase II BEAVER trial.
Not available
S-EPMC12873207 | biostudies-literature
UnknownPARP inhibitor radiosensitization enhances anti-PD-L1 immunotherapy through stabilizing chemokine mRNA in small cell lung cancer.
Not available
S-EPMC11880360 | biostudies-literature
UnknownLongitudinal single-cell analysis of a myeloma mouse model identifies subclonal molecular programs associated with progression.
Not available
S-EPMC8566524 | biostudies-literature
UnknownWhole genome and transcriptome profiling in advanced pancreatic cancer patients on the COMPASS trial.
Not available
S-EPMC12219293 | biostudies-literature
UnknownLatency and interval therapy affect the evolution in metastatic colorectal cancer.
Not available
S-EPMC6969060 | biostudies-literature
UnknownA Tailored Electronic Survivorship Care Plan for Prostate Cancer Survivors: A Multicenter Randomized Controlled Trial.
Not available
S-EPMC12708024 | biostudies-literature
Sort   by:  
 Page size